Immatics at the CAR-TCR Summit 2018 (Sept 4-7) in Boston, MA

| News, USA

Immatics is part of the CAR-TCR Summit 2018 in Boston (Sept 4-7)! Join our experts and have interesting discussions.


September 4th, 12:00pm-2:00pm

Workshop I: "Manufacturing of TCR Based T Cells for Solid Tumors: Experience and Lessons Learned

Chair: Ali Mohamed (Vice President CMC, Immatics US)


September 5th


"Multivalent TCR-T Therapy Using Novel Targets"

Speaker: Steffen Walter (CSO, Immatics US)

Session: "CAR-TCR Discovery"



Plenary Session: "How to make CAR/TCR Therapies work beyond the CD19/ALL Paradigm?"

Chair: Steffen Walter (CSO, Immatics US)


September 6th, 8:00am-9:15am

Poster 1: "Manufacturing of TCR-engineered T cells in 5-6 days

Poster 2: "The ACTolog® Approach: Multi-target Adoptive Cell Therapy using Endogenous Antigen Specific T cells

Presenter: Geoffrey Stephens (Director Product Science, Immatics US), Steffen Walter (CSO, Immatics US)


September 7th, 8:45am-3:30pm

Focus Day: "Overcoming CAR-T Toxicity in Solid Tumors

Chair: Ali Mohamed (Vice President CMC, Immatics US)


Further information on CAR-TCR Summit here.

Press Contact

Anja Heuer

Corporate Communications,
Immatics Biotechnologies GmbH

+49 89 540 415 606

Go back

We use cookies to ensure that we give you the best experience on our website.